Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005
Published online before print June 23, 2005, doi: 10.1161/01.RES.0000174614.74469.83
A more recent version of this article appeared on July 22, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
97/2/125    most recent
01.RES.0000174614.74469.83v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez-Vita, J.
Right arrow Articles by Egido, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Vita, J.
Right arrow Articles by Egido, J.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
Right arrow Hypertension - basic studies
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology

Submitted on May 10, 2004
Revised on May 4, 2005
Accepted on June 13, 2005

Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-{beta}, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells

J. Rodriguez-Vita ; Marta Ruiz-Ortega *; M. Rupérez ; V. Esteban ; E. Sanchez-López ; J. J. Plaza ; and J. Egido

From the Vascular and Renal Research Laboratory, Fundación Jiménez Diaz, Universidad Autónoma Madrid, Spain

* To whom correspondence should be addressed. E-mail: mruizo{at}fjd.es.

Endothelin (ET)-1 is a potent vasoconstrictor that participates in cardiovascular diseases. Connective tissue growth factor (CTGF) is a novel fibrotic mediator that is overexpressed in human atherosclerotic lesions, myocardial infarction, and experimental models of hypertension. In vascular smooth muscle cells (VSMCs), CTGF regulates cell proliferation/apoptosis, migration, and extracellular matrix (ECM) accumulation. Our aim was to investigate whether ET-1 could regulate CTGF and to investigate the potential role of ET-1 in vascular fibrosis. In growth-arrested rat VSMCs, ET-1 upregulated CTGF mRNA expression, promoter activity, and protein production. The blockade of CTGF by a CTGF antisense oligonucleotide decreased FN and collagen expression in ET-1-treated cells, showing that CTGF participates in ET-1-induced ECM accumulation. The ETA, but not ETB, antagonist diminished ET-1-induced CTGF gene and production. Several intracellular signals elicited by ET-1, via ETA receptors, are involved in CTGF synthesis, including activation of RhoA/Rho-kinase and mitogen-activated protein kinase and production of reactive oxygen species. CTGF is a mediator of TGF-{beta}- and angiotensin (Ang) II-induced fibrosis. In VSMCs, ET-1 did not upregulate TGF-{beta} gene or protein. The presence of neutralizing transforming growth factor (TGF)-{beta} antibody did not modify ET-1-induced CTGF production, showing a TGF-{beta}-independent regulation. We have also found an interrelationship between Ang II and ET-1 because the ETA antagonist diminished CTGF upregulation caused by Ang II. Collectively, our results show that, in cultured VSMCs, ET-1, independently of TGF-{beta} and through the activation of several intracellular signals via ETA receptors, regulates CTGF. This novel finding suggests that CTGF could be a mediator of the profibrotic effects of ET-1 in vascular diseases.


Key words: endothelin-1 • connective tissue growth factor • signal transduction • vascular smooth muscle cells • extracellular matrix




This article has been cited by other articles:


Home page
J R Soc InterfaceHome page
A Valentin, L Cardamone, S Baek, and J.D Humphrey
Complementary vasoactivity and matrix remodelling in arterial adaptations to altered flow and pressure
J R Soc Interface, March 6, 2009; 6(32): 293 - 306.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Humphrey
Mechanisms of Arterial Remodeling in Hypertension: Coupled Roles of Wall Shear and Intramural Stress
Hypertension, August 1, 2008; 52(2): 195 - 200.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
A. P. Gomez, M. J. Moreno, A. Iglesias, P. X. Coral, and A. Hernandez
Endothelin 1, its Endothelin Type A Receptor, Connective Tissue Growth Factor, Platelet-Derived Growth Factor, and Adrenomedullin Expression in Lungs of Pulmonary Hypertensive and Nonhypertensive Chickens
Poult. Sci., May 1, 2007; 86(5): 909 - 916.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido
TGF-{beta} signaling in vascular fibrosis
Cardiovasc Res, May 1, 2007; 74(2): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Castanares, M. Redondo-Horcajo, N. Magan-Marchal, P. ten Dijke, S. Lamas, and F. Rodriguez-Pascual
Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation
J. Cell Sci., April 1, 2007; 120(7): 1256 - 1266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Milliat, A. Francois, M. Isoir, E. Deutsch, R. Tamarat, G. Tarlet, A. Atfi, P. Validire, J. Bourhis, J.-C. Sabourin, et al.
Influence of Endothelial Cells on Vascular Smooth Muscle Cells Phenotype after Irradiation: Implication in Radiation-Induced Vascular Damages
Am. J. Pathol., October 1, 2006; 169(4): 1484 - 1495.
[Abstract] [Full Text] [PDF]